CoChat

Thyroid safety in patients treated with liraglutide

Gallo, M. · 2013 · Journal of Endocrinological Investigation

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

During the last years, various novel anti-diabetic drugs have considerably enriched the therapeutic armamentarium for subjects with Type 2 diabetes. In the meantime, much interest has recently been focused on the potential cardiovascular and oncological adverse effects of these new therapies. As to glucagon-like peptide 1 (GLP-1) analogs, medullary thyroid tumors were reported to be more common in rodent toxicology studies with liraglutide, although the relevance of this finding in humans has been questioned. Analyses of sequential changes in calcitonin levels in several thousands of subjects did not reveal a relationship between liraglutide therapy and plasma calcitonin. Furthermore, no medullary thyroid cancer has been detected in humans taking liraglutide. Nevertheless, the long-term consequences of sustained GLP-1 receptor activation in the human thyroid remain unknown and deserve further investigation.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf03346749

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 27

Metadata

Authors
Gallo, M.
Affiliations
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
Corresponding author
Gallo, M.
Venue
Journal of Endocrinological Investigation
Published
2013-02
Volume
36
Issue
2
Pages
140-145
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
OpenAlex
W2086006571
Cited by
27
References
45
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 1 · 2021: 4 · 2020: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2014: 1 · 2013: 1
FWCI
0.20
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Endocrinological Investigation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
liraglutide, medullary thyroid carcinoma, GLP-1 receptor agonists, type 2 diabetes, calcitonin, drug safety
MeSH terms
Liraglutide, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Thyroid Gland, Thyroid Neoplasms, Randomized Controlled Trials as Topic, Treatment Outcome, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.